DND Technologies, Inc. (DNDT)

Market Cap	11.43M +548.0%
Revenue (ttm)	n/a
Net Income	-26.17K
EPS	n/a
Shares Out	29.40M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,385
Open	0.5260
Previous Close	0.7801
Day's Range	0.2500 - 0.5260
52-Week Range	0.0571 - 1.7520
Beta	-4.00
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About DND Technologies

DND Technologies, Inc., a holding company, produces and sells various specialty balms. It also manufactures and distributes pharmaceutical products, including Bioassaygen Gel to reduce wrinkles and promote natural skin re-genesis; Bioassaygen Cosmetic Mask for vanity applications; Bioassaygen Bio-Skin, a skin replacement bandage; and Bioassaygen Delivery Gel that accelerates natural skin re-genesis. The company distributes its products through wholesale, retail, and Internet. DND Technologies, Inc. was founded in 1997 and is based in New York, ...

• Industry: Beverages - Non-Alcoholic
• Sector: Consumer Staples
• Founded: 1997
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: DNDT

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 26, 2026

Data Sources Report a data error